ArticleFrontiers in public health2025
Global, regional, and national burdens of pancreatitis in children and adolescents aged 0-24 years from 1992 to 2021: a trend analysis based on the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acute and Recurrent Pancreatitis in Children: Insights into Etiology and Clinical Course from a Retrospective Single-Center Study.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The younger onset of pancreatitis presents a significant public health challenge. This study aims to analyze the global burden of pancreatitis in younger populations based on the Global Burden of Disease 2021. Methods: This study uses incidence rates and Disability-Adjusted Life Years (DALYs) to assess the burden of pancreatitis. Joinpoint modeling was used to assess the trend of the burden. Age-Period-Cohort (APC) modeling was used to assess the annual percentage changes by age, as well as the period and cohort relative risks. Norpred modeling was used to predict the burden through 2040. Results: In 2021, the global incidence of pancreatitis among younger individuals was 9.16/100,000 (95% UI 5.74-13.85), with an annual average percentage change (AAPC) of 0.13 (95% CI 0.12-0.14). The DALYs was 6.36/100,000 (95% UI 5.21-7.97), with an AAPC of -0.93 (95% CI -1.01 to -0.85). Global incidence rates of pancreatitis have notably increased since 1999, while the overall burden of DALYs has decreased over the past 30 years. In the APC model, different age groups experienced varying risks. According to the Norpred predictive model, by 2040, the global incidence of pancreatitis among younger individuals is projected to reach 313,567 cases, with an incidence rate of 9.07/100,000. Conclusion: Globally, the incidence of pancreatitis in younger individuals has increased over the past three decades. Urgent policy interventions are needed to address healthcare inequities and alleviate this burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.